French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading ->
The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading ->
A World Health Organization emergency committee met Thursday to determine if the monkeypox outbreak spreading in non-endemic countries constitutes a Public Health Emergency of International Concern (PHEIC). The closed door meeting, including 16 committee members and eight advisors, will make a recommendation to WHO Director-General Dr Tedros Adhanom Ghebreyesus, who will decide whether to designate […] Continue reading ->
The World Trade Organization’s Director General Dr Ngozi Okonjo Iweala said she was “cautiously optimistic” about the potential for WTO members to reach long-delayed agreements on issues such as a limited IP waiver for COVID vaccines as well as a decision to curb harmful fisheries subsidies that allow big industrial rigs to plunder the oceans  […] Continue reading ->
Africa has the scientific and intellectual capital to develop new interventions to tackle global health challenges. Particularly when local problems emerge, surely local research is the best path towards a solution. But pursuing this path requires funding that will support and promote the growth and expertise of Africa’s scientists.  Africa is plagued by many epidemics […] Continue reading ->